Herbert V, Colman N, Palat D, Manusselis C, Drivas G, Block E, Akerkar A, Weaver D, Frenkel E
J Lab Clin Med. 1984 Nov;104(5):829-41.
In a study from four laboratories using two commercial vitamin B12 radioassays (impure hog intrinsic factor concentrate containing both intrinsic factor and R binders (IF + R) to measure total corrinoids and the same concentrate presaturated with cobinamide (Cbi) to block B12 binding sites on R binder (IF + R + Cbi) to measure only cobalamins), the rank order of results was generally the same. The concordance between the two tests for classifying sera as normal or deficient was 91% in 311 serum samples. Three percent of sera below the "true B12" (B12 binding to IF + R + Cbi) normal cut-off point were not below the cut-off point for normal "total B12" (B12 binding to IF + R); 6% of sera below the total B12 normal cut-off point were not below true B12 cut-off point. The correlations between Euglena gracilis and the radioassays were 0.80 and 0.83 in the 50 serum samples that also had E. gracilis serum vitamin B12 levels. Lactobacillus leichmannii serum vitamin B12 levels were determined in 49 of the 311 serum samples and results were comparable with results obtained by four radioassay binder systems: IF + R, IF + R + Cbi, highly purified hog IF, and saliva R binder. The closest correlate with L. leichmannii was radioassay using IF + R as binder (r = 0.93), then IF + R + Cbi (r = 0.92), pure IF (r = 0.80), and pure R (r = 0.73). The key to reliable results appears not to reside in a particular assay but rather in determining for each assay its own range of results in participants determined clinically and morphologically normal vs. participants with deficient vitamin B12 (with B12 deficiency defined independently of a serum B12 assay). When laboratory assay results differ from clinical judgment, further evaluation is the appropriate course. There is no "gold standard" for human serum vitamin B12 assay.
在一项来自四个实验室的研究中,使用两种商业维生素B12放射免疫测定法(不纯的猪内因子浓缩物,同时含有内因子和R结合蛋白(IF + R)以测量总类咕啉,以及用钴胺酰胺(Cbi)预饱和的相同浓缩物以阻断R结合蛋白上的B12结合位点(IF + R + Cbi)以仅测量钴胺素),结果的排序通常是相同的。在311份血清样本中,两种检测将血清分类为正常或缺乏的一致性为91%。低于“真实B12”(B12与IF + R + Cbi结合)正常临界值的血清中有3%未低于正常“总B12”(B12与IF + R结合)的临界值;低于总B12正常临界值的血清中有6%未低于真实B12临界值。在50份同时有纤细裸藻血清维生素B12水平的血清样本中,纤细裸藻与放射免疫测定法的相关性分别为0.80和0.83。在311份血清样本中的49份中测定了莱氏乳杆菌血清维生素B12水平,结果与通过四种放射免疫测定结合系统获得的结果相当:IF + R、IF + R + Cbi、高度纯化的猪IF和唾液R结合蛋白。与莱氏乳杆菌最密切相关的是使用IF + R作为结合剂的放射免疫测定法(r = 0.93),然后是IF + R + Cbi(r = 0.92)、纯IF(r = 0.80)和纯R(r = 0.73)。可靠结果的关键似乎不在于特定的检测方法,而在于为每种检测方法确定其在临床和形态学上确定为正常的参与者与维生素B12缺乏的参与者(维生素B12缺乏的定义独立于血清B12检测)中的自身结果范围。当实验室检测结果与临床判断不同时,进一步评估是合适的做法。人体血清维生素B12检测没有“金标准”。